ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A New Prognostic Strategy Based on four DNA Repair-Associated lncRNAs for Hepatocellular Carcinoma

Zeng, Hanyi; Liu, Chengdong; Zhou, Xiaohan; Liu, Li*南方医科大学
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING2022DOI: 10.2174/1386207324666210302091432
4被引20阅读
引用收藏
分享

摘要

Background: Hepatocellular carcinoma (HCC) is a malignant tumour with a poor prognosis. The effect of DNA repair on prognosis cannot be ignored, and long non-coding RNA (lncRNA) can regulate the DNA repair process. Objective: To obtain DNA repair-associated lncRNA (DR-lncRNA) prognostic signature for improving the ability to predict HCC prognosis. Methods: Our study used the Cancer Genome Atlas database. Gene set variation analysis was performed to differentiate high and low levels of DNA repair to identify DR-lncRNAs. By performing univariate Cox regression, LASSO regression, and multivariate Cox regression analyses, we finally obtained a DR-lncRNA prognostic signature and constructed a nomogram prognostic model. Time-dependent receiver operating characteristic (ROC) curves, calibration plots, decision curve analysis (DCA), and clinical impact curves were used to assess predictive ability and clinical utility. Differentially expressed genes (DEGs) functional enrichment analysis was performed to further explore the underlying mechanisms that influence HCC prognosis. Results: We obtained the following DR-lncRNA prognostic signature:AP002478.1, AC116351.1, LINC02580, and LINC00861. The ROC curves and calibration plots showed good discrimination and calibration properties. Combining the DR-lncRNA prognostic signature and tumour stages, we established a nomogram prognostic model. DCA and clinical impact curves showed the clinical utility of this model. DEGs of high-risk and low-risk groups predicted by the prognostic DRlncRNA were significantly associated with cell cycle, various metabolic pathways and biological processes, such as the oxidation-reduction process and cell division. Conclusion: We identified a DR-lncRNA prognostic signature and constructed a nomogram prognostic model, which could be a beneficial prognostic strategy for HCC.

学科与关键词

关键词
Hepatocellular carcinomaDNA repairprognosislncRNA signaturenomogram modelhepatocytes
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
发表日期
2022
卷期
第 25 卷, 第 5 期
页码
906-918
DOI
10.2174/1386207324666210302091432
语言
ENGLISH
成果收录
SCIE
资助标注
National Nature Science Foundation of China [81773008, 81672756, 81872399, 81972897]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Natural Science Foundation of Guangdong Province [2017A030311023]; Guangzhou Technology Project [201804010044]

作者

  • Z

    Zeng, Hanyi (第一作者)

    southern med univ

  • L

    Liu, Chengdong

    southern med univ

查看全部 4 位作者收起作者
  • Z

    Zhou, Xiaohan

    southern med univ

  • L

    Liu, Li (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417